Bisphosphonates Cause Osteonecrosis of the Jaw-Like Disease in Mice

被引:149
作者
Bi, Yanming [2 ]
Gao, Yamei [1 ]
Ehirchiou, Driss [1 ]
Cao, Chunzhang [1 ]
Kikuiri, Takashi [3 ]
Le, Anh [3 ]
Shi, Songtao [3 ]
Zhang, Li [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Physiol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA
[2] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA
[3] Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA
基金
美国国家卫生研究院;
关键词
ZOLEDRONIC ACID; BONE; OSTEOCLAST; APOPTOSIS; CANCER; DEXAMETHASONE; DOCETAXEL;
D O I
10.2353/ajpath.2010.090592
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Bisphosphonate-associated osteonecrosis of the jaw (BONJ) is a morbid bone disease linked to long-term bisphosphonate use. Despite its broad health impact, mechanistic study is lacking. In this study, we have established a mouse model of BONJ-like disease based on the equivalent clinical regimen in myeloma patients, a group associated with high risk of BONJ. We demonstrate that the murine BONJ-like disease recapitulates major clinical and radiographical manifestations of the human disease, including characteristic features of osseous sclerosis, sequestra, avascular, and radiopaque alveolar bone in the jaw that persists beyond a normal course of wound healing following tooth extraction. We find that long-term administration of bisphosphonates results in an increase in the size and number of osteoclasts and the formation of giant osteoclast-like cells within the alveolar bone. We show that the development of necrotic bone and impaired soft tissue healing in our mouse model is dependent on long-term use of high-dose bisphosphonates, immunosuppressive and chemotherapy drugs, as well as mechanical trauma. Most importantly, we demonstrate that bisphosphonate is the major cause of BONJ-like disease in mice, mediated in part by its ability to suppress osseous angiogenesis and bone remodeling. The availability of this novel mouse model of BONJ-like disease will help elucidate the pathophysiology of BONJ and ultimately develop novel approaches for prevention and treatment of human BONJ. (Am J Pathol 2010, 177:280-290; DOI: 10.2353/ajpath.2010.090592)
引用
收藏
页码:280 / 290
页数:11
相关论文
共 26 条
[2]   Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].
Bamias, A ;
Kastritis, E ;
Bamia, C ;
Moulopoulos, LA ;
Melakopoulos, L ;
Bozas, G ;
Koutsoukou, V ;
Gika, D ;
Anagnostopoulos, A ;
Papadimitriou, C ;
Terpos, E ;
Dimopoulos, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587
[3]   Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche [J].
Bi, Yanming ;
Ehirchiou, Driss ;
Kilts, Tina M. ;
Inkson, Colette A. ;
Embree, Mildred C. ;
Sonoyama, Wataru ;
Li, Li ;
Leet, Arabella I. ;
Seo, Byoung-Moo ;
Zhang, Li ;
Shi, Songtao ;
Young, Marian F. .
NATURE MEDICINE, 2007, 13 (10) :1219-1227
[4]   Blood vessels form a scaffold for neuroblast migration in the adult olfactory bulb [J].
Bovetti, Serena ;
Hsieh, Yi-Chun ;
Bovolin, Patrizia ;
Perroteau, Isabelle ;
Kazunori, Toida ;
Puche, Adam C. .
JOURNAL OF NEUROSCIENCE, 2007, 27 (22) :5976-5980
[5]   Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease [J].
Dunstan, Colin R. ;
Felsenberg, Dieter ;
Seibel, Markus J. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (01) :42-55
[6]  
Durie BGM, 2005, NEW ENGL J MED, V353, P99
[7]   In vivo effects of bisphosphonates on the osteoclast mevalonate pathway [J].
Fisher, JE ;
Rodan, GA ;
Reszka, AA .
ENDOCRINOLOGY, 2000, 141 (12) :4793-4796
[8]   Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere) [J].
Grant, DS ;
Williams, TL ;
Zahaczewsky, M ;
Dicker, AP .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (01) :121-129
[9]   Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis [J].
Hansen, T ;
Kunkel, M ;
Weber, A ;
Kirkpatrick, CJ .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2006, 35 (03) :155-160
[10]  
HUGHES DE, 1995, J BONE MINER RES, V10, P1478